함께 비교하는 진짜 ADC · Antibody · CGT 데이터

ADCBiologicstaleMultiple Myeloma Research Conso…Phase 2

Selinexor, dexamethasone, ixazomib, pomalidomide (Selinexor, dexamethasone, ixazomib, pomalidomide)

Relapsed Refractory Multiple Myeloma · FRα

#FR#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

ADCBiologicstaleMultiple Myeloma Research Conso…Phase 2

Venetoclax, dexamethasone, ixazomib, pomalidomide (Venetoclax, dexamethasone, ixazomib, pomalidomide)

Relapsed Refractory Multiple Myeloma · FRα

#FR#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

ADCBiologicstaleVerastem, Inc.Phase 2

Defactinib Hydrochloride (Defactinib Hydrochloride)

Advanced Lymphoma; Advanced Malignant Solid Neoplasm · FRα

#FR#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3

효능 ORR 3.2%임상시험 3상태 RECRUITING

ADCBiologicstaleMacroGenicsPhase 2

vobramitamab duocarmazine (vobramitamab duocarmazine)

Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Cancer · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3

효능 ORR 45.8%임상시험 3상태 DISCONTINUED

ADCBiologicstaleAbbViePhase 3

Vasoconstrictor eye drops (Vasoconstrictor eye drops)

Glioblastoma Multiforme · Glioblastoma Multiforme

#GlioblastomaMultiforme#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+1

CGTBiologicstaleBeijing BiotechPhase 1

CD20/BCMA-directed CAR-T cells (CD20/BCMA-directed CAR-T cells)

Systemic Lupus Erythematosus (SLE); Immune-mediated Necrotizing Myopathy (IMNM) · CD20

#CD20#CGT#Phase1#세포유전치료#CAR-T+4

ADCBiologicstaleNational Center for Complementa…Phase 2

MAD CP (MAD CP)

Non-hodgkin Lymphoma; Hodgkin Lymphoma · Non-hodgkin Lymphoma

#Non-hodgkinLymphoma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

CGTBiologicstaleImmunityBio, Inc.Phase 2

PSA-based Oncolytic Virus (ETBX-071, ETBX-071 (PSA-based Oncolytic Virus))

High-risk Prostate Cancer · High-risk Prostate Cancer

#High-riskProstateCancer#CGT#Phase2#세포유전치료#CAR-T+2

효능 ORR 0%임상시험 3상태 DISCONTINUED

ADCBiologicstaleGilead SciencesPhase 2

IMMU 130 (IMMU 130)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1

ADCBiologicstaleBioAtla, Inc.Phase 2

CAB-AXL-ADC (CAB-AXL-ADC)

Undifferentiated Pleomorphic Sarcoma; Myxofibrosarcoma · Undifferentiated Pleomorphic Sarcoma

#UndifferentiatedPleomorphicSarco#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

CGTBiologicstaleBeijing BiotechPhase 2

EB-DT-CAR-NK (EB-DT-CAR-NK)

Advanced Gastric Adenocarcinoma; Advanced Gastroesophageal Junction Adenocarcinoma · Advanced Gastric Adenocarcinoma

#AdvancedGastricAdenocarcinoma#CGT#Phase2#세포유전치료#CAR-T+3

ADCBiologicstaleNader SanaiPhase 1

Risvutatug rezetecan (Risvutatug rezetecan)

Glioblastoma (GBM); Brain Metastasases · Glioblastoma (GBM)

#GlioblastomaGBM#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2

CGTBiologicstaleNkarta, Inc.Phase 1

NKG2D CAR-NK (NKG2D CAR-NK)

AML · AML

#AML#CGT#Phase1#세포유전치료#CAR-T+2

ADCBiologicstaleHenry Ford Health SystemPhase 1

sacituzumab govitecan (Trodelvy, Sacituzumab govetican)

Gastrointestinal Cancer · Gastrointestinal Cancer

#GastrointestinalCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1

ADCBiologicstaleRemeGenPhase 2

disitamab vedotin (Disitamab Vedotin, RC48, disitamab vedotin, sintilimab, capecitabine)

Rectal Cancer · Rectal Cancer

#RectalCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1

CGTBiologicstaleNational Cancer Institute (NCI)Phase 2

autologous anti-MART-1 F5 T-cell receptor (autologous anti-MART-1 F5 T-cell receptor)

Melanoma; Skin Cancer · Melanoma

#Melanoma#CGT#Phase2#세포유전치료#CAR-T+3

ADCBiologicstaleAstraZenecaPLPhase 2

AZD8205 (AZD8205)

Breast Cancer; Biliary Tract Carcinoma · Breast Cancer

#BreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+4

ADCBiologicstaleGI Innovation, Inc.Phase 2

GI-102 (GI-102)

Advanced Solid Tumor; Metastatic Solid Tumor · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3

CGTBiologicstaleNational Cancer Institute (NCI)Phase 2

Anti-NY ESO-1 T-cell receptor PBL (Anti-NY ESO-1 T-cell receptor PBL)

Metastatic Melanoma; Metastatic Renal Cell Cancer · Metastatic Melanoma

#MetastaticMelanoma#CGT#Phase2#세포유전치료#CAR-T+3

AntibodystaleSutro Biopharma, Inc.Phase 3

Luveltamab tazevibulin (Luveltamab tazevibulin)

Ovarian Cancer; Epithelial Ovarian Cancer · Ovarian Cancer

#OvarianCancer#Antibody#Phase3#항체#면역항체+3

ADCBiologicstaleCancer Institute and Hospital, …Phase 2

QH101 (QH101)

Rare Malignant Neoplasm; Advanced Solid Tumors · Rare Malignant Neoplasm

#RareMalignantNeoplasm#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

ADCBiologicstaleCancer Institute and Hospital, …Phase 2

IDOV-SAFE (IDOV-SAFE)

Rare Malignant Neoplasm; Advanced Solid Tumors · Rare Malignant Neoplasm

#RareMalignantNeoplasm#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

ADCBiologicstaleConvalife (Shanghai) Co., Ltd.Phase 2

CVL006 (CVL006)

Rare Malignant Neoplasm; Advanced Solid Tumors · Rare Malignant Neoplasm

#RareMalignantNeoplasm#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2